Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1142910 | 0.98 | LMNA (0.35) | LMNASLC1A3SLC1A2SLC1A1MEN1 | |
| SCHEMBL1143117 | 0.80 | LMNA (0.41) | LMNASLC1A3SLC1A2SLC1A1NAAA | |
| SCHEMBL10072107 | 0.78 | LMNA (0.42) | LMNASLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL1143120 | 0.78 | LMNA (0.38) | LMNASLC1A3SLC1A2SLC1A1NAAA | |
| SCHEMBL3821994 | 0.78 | EPHX1 (0.40) | LMNASLC1A3SLC1A2SLC1A1MEN1 | |
| SCHEMBL1143159 | 0.77 | LMNA (0.42) | LMNASLC1A3SLC1A2SLC1A1NAAA | |
| SCHEMBL14975446 | 0.77 | — | — | |
| SCHEMBL1142659 | 0.76 | SLC1A3 (0.38) | LMNASLC1A3SLC1A2SLC1A1NAAA | |
| SCHEMBL14975548 | 0.76 | — | — | |
| SCHEMBL13979022 | 0.76 | EPHX1 (0.42) | KMT2AEPHX1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3204159-B1 | PROCESS FOR PREPARING SPHERICAL POLYMERIZATION CATALYST COMPONENTS FOR USE IN OLEFIN POLYMERIZATIONS | GRACE W R & CO (US) | 2020-12-16 | — | — | EP | disclosed |
| EP-2701843-B1 | EMULSION PROCESS FOR IMPROVED LARGE SPHERICAL POLYPROPYLENE CATALYSTS | W R GRACE & CO -CONN (US) | 2017-11-29 | — | — | EP | disclosed |
| US-9714302-B2 | Process for preparing spherical polymerization catalyst components for use in olefin polymerizations | W. R. Grace & Co.—Conn. (US) | 2017-07-25 | — | — | US | disclosed |
| US-9403924-B2 | Process of production of large and spherical polymerization catalyst and use of same in olefin polymerizations | BASF CORPORATION (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150361194-A1 | PROCESS OF PRODUCTION OF LARGE AND SPHERICAL POLYMERIZATION CATALYST AND USE OF SAME IN OLEFIN POLYMERIZATIONS | W. R. GRACE & CO.-CONN. | 2015-12-17 | — | — | US | disclosed |
| EP-2782938-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF Corporation (US) | 2014-10-01 | — | — | EP | disclosed |
| US-8569195-B2 | Internal and external donor compounds for olefin polymerization catalysts II | BASF CORPORATION (US) | 2013-10-29 | — | — | US | disclosed |
| WO-2013077837-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF CORPORATION (US) | 2013-05-30 | — | — | WO | disclosed |
| US-20110207901-A1 | INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II | BASF CATALYSTS LLC (US) | 2011-08-25 | — | — | US | disclosed |
| US-8003559-B2 | Internal donor for olefin polymerization catalysts | BASF CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110034651-A1 | MIXED DONOR SYSTEM FOR HIGH MELT FLOW AND HIGH ACTIVITY | BASF CATALYSTS LLC (US) | 2011-02-10 | — | — | US | disclosed |
| US-20090286672-A1 | INTERNAL DONOR FOR OLEFIN POLYMERIZATION CATALYSTS | BASF CATALYSTS LLC (US) | 2009-11-19 | — | — | US | disclosed |